Home/Keli Therapeutics/Neringa Kaminskiene, MPharm

NK

Neringa Kaminskiene, MPharm

Chief Quality Officer

Keli Therapeutics

Therapeutic Areas

Orthopedics Nephrology Inflammatory Diseases Dermatology

Keli Therapeutics Pipeline

Drug	Indication	Phase
RECARTA	Knee Cartilage Damage	Pre-clinical/Early Clinical
ETHOCELL	Osteoarthritic Knee Cartilage / Inflammatory Conditions	Pre-clinical/Early Clinical
AKI Program	Acute Kidney Injury	Clinical Trial Launch

Leadership Team at Keli Therapeutics

Justinas Maciulaitis, MD, PhD

Founder, Chief Executive Officer, Board Member

Ruta Insodaite, PhD

Chief Manufacturing Officer

Ruta Augliene, MD, PhD

Chief Medical Officer

Dr. Sohail Ahmed

Director on the Board

View full Keli Therapeutics profile